TG Therapeutics Inc [TGTX] stock prices are up 4.95% to $38.92 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TGTX shares have gain 8.17% over the last week, with a monthly amount glided 1.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, TD Cowen started tracking the stock with Buy rating on October 29, 2024, and set its price target to $50. On August 02, 2023, upgrade upgraded it’s rating to Neutral and revised its price target to $12 on the stock. BofA Securities initiated its recommendation with a Underperform and recommended $5 as its price target on May 20, 2022. B. Riley Securities reiterated a Buy rating for this stock on February 23, 2022, and downed its price target to $35. In a note dated November 15, 2021, Goldman downgraded an Sell rating on this stock and revised its target price from $33 to $26.
The stock price of TG Therapeutics Inc [TGTX] has been fluctuating between $16.65 and $46.48 over the past year. Currently, Wall Street analysts expect the stock to reach $19.8 within the next 12 months. TG Therapeutics Inc [NASDAQ: TGTX] shares were valued at $38.92 at the most recent close of the market. An investor can expect a potential drop of -49.13% based on the average TGTX price forecast.
Analyzing the TGTX fundamentals
The TG Therapeutics Inc [NASDAQ:TGTX] reported sales of 386.39M for trailing twelve months, representing a surge of 90.40%. Gross Profit Margin for this corporation currently stands at 0.87% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.19 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 37.28 points at the first support level, and at 35.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 39.77, and for the 2nd resistance point, it is at 40.62.
Ratios To Look Out For
It’s worth pointing out that TG Therapeutics Inc [NASDAQ:TGTX]’s Current Ratio is 4.02. In addition, the Quick Ratio stands at 3.04 and the Cash Ratio stands at 0.82. Considering the valuation of this stock, the price to sales ratio is 15.99, the price to book ratio is 25.94 and price to earnings (TTM) ratio is 159.51.
Transactions by insiders
Recent insider trading involved Echelard Yann, Director, that happened on Jun 13 ’25 when 10000.0 shares were sold. Director, Echelard Yann completed a deal on Jun 13 ’25 to buy 10000.0 shares. Meanwhile, CFO Power Sean A sold 11337.0 shares on Jan 03 ’25.
